Pharmafile Logo

Autoimmune conditions: Living With syndicated patient reports

April 11, 2024 |  

- PMLiVE

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care.

In our Living With syndicated patient reports, we have interviewed hundreds of autoimmune patients and caregivers throughout the years. Quantitative and qualitative methodologies are combined to provide powerful insights about patient journeys to diagnosis, and the burden on patients living with conditions such as: Crohn’s Disease, Lupus, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Systemic Sclerosis and Ulcerative Colitis.

Find out more about the reports. 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Biosimilars: Bringing patients into the conversation

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...

Pharmaceutical Market Research Conference 2017

We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.

Shifting perceptions of the use of probiotics in IBS Management

Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range...

Nutraceuticals in India: A Challenging Opportunity

Published in eyeforpharma December 2016 by Marc Yates

Research Partnership makes annual donation to Forever Projects

Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects

A Bitter Pill?

The ideal route of admin isn’t clear cut in the global marketplace

Understanding the chronic disease patient journey in emerging markets

In this paper, we will explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these...